Featured 13F manager
DME Capital Management David Einhorn
New York, NY 20 processed 13Fs on this site · 2021 Q3–2026 Q2
- $3.9B
- 46 holds
- 2026 Q2
- +22.5% QoQ
- Top 5 38.2%
David Einhorn files DME Capital Management as a Form 13F. The latest book is 2026 Q2 at $3.9B, up 22.5% QoQ, led by Green Brick Partners, Fluor, and Core Natural Resources.
Portfolio
top 5 38.2% · top 10 52.8%
- GRBK - Green Brick Partners 19.4%
- FLR - Fluor 6.2%
- CNR - Core Natural Resources 4.7%
- BHF - Brighthouse Finl 4.6%
- ACHC — 3.3%
- PENN - Penn Entertainment 3.2%
- FBIN - Fortune Brands 3.1%
- PCG - Pg And E 2.9%
- CNC - Centene Del 2.7%
- PKG - Graphic Packaging 2.7%
- SNX - Td Synnex 2.6%
- TEVA - Teva Pharmaceutical Inds 2.5%
- Other 42.1%
AUM over time
Book
| GRBK - Green Brick Partners | Hold | 9,467,383 | $58.31 | $552M | — | — | |
| CNR - Core Natural Resources | New | 2,208,640 | $77.10 | $170M | +2,208,640 | +$170M | |
| BHF - Brighthouse Finl | Reduce −1.2% | 2,801,097 | $57.99 | $162M | −34,000 | +$26M | |
| KD - Kyndryl | Add +9.9% | 4,135,207 | $31.40 | $130M | +372,765 | −$335K | |
| PENN - Penn Entertainment | Add +9.0% | 6,268,440 | $16.31 | $102M | +520,000 | −$12M | |
| CNH - Cnh Indl | Reduce −21.1% | 8,076,540 | $12.28 | $99M | −2,158,180 | −$17M | |
| HPQ - HP | Add +43.0% | 3,018,770 | $27.69 | $84M | +908,090 | +$15M | |
| TECK - Teck Resources · CL B | Add +84.0% | 2,000,000 | $36.43 | $73M | +913,337 | +$29M | |
| DHT — | Add +26.0% | 6,610,934 | $10.50 | $69M | +1,364,950 | +$21M | |
| CPRI - Capri | Add +65.4% | 3,479,107 | $19.73 | $69M | +1,375,390 | +$24M | |
| LBTYA - Liberty Global · CL A | Add +34.4% | 5,220,502 | $11.51 | $60M | +1,335,244 | +$11M | |
| ROIV - Roivant Sciences | Add +3.2% | 5,441,167 | $10.09 | $55M | +170,100 | −$7M | |
| VTRS - Viatris | Add +3.7% | 6,000,830 | $8.71 | $52M | +215,720 | −$20M | |
| GLD - Spdr Gold Tr | Reduce −10.8% | 180,151 | $288.14 | $52M | −21,790 | +$3M | |
| SDRL - Seadrill | Add +106.8% | 1,588,828 | $25.00 | $40M | +820,663 | +$10M | |
| CNC - Centene Del | Reduce −37.1% | 547,570 | $60.71 | $33M | −322,930 | −$19M | |
| DLTR - Dollar Tree | New | 436,360 | $75.07 | $33M | +436,360 | +$33M | |
| PTON - Peloton Interactive · CL A | Reduce −52.5% | 5,003,408 | $6.32 | $32M | −5,519,279 | −$60M | |
| PKG - Graphic Packaging | Hold | 1,047,100 | $25.96 | $27M | — | — | |
| WFRD - Weatherford Intl | Hold | 456,639 | $53.55 | $24M | — | — | |
| LKFT - Galapagos | Add +0.7% | 482,746 | $25.12 | $12M | +3,383 | −$1M | |
| COYA - Coya Therapeutics | Hold | 1,646,440 | $6.47 | $11M | — | — | |
| TEVA - Teva Pharmaceutical Inds | Add +21.3% | 568,200 | $15.37 | $9M | +99,650 | −$2M | |
| ALITEUR - Alight · CL A | Reduce −70.2% | 1,000,000 | $5.93 | $6M | −2,353,026 | −$17M | |
| SNX - Td Synnex | Reduce −14.1% | 46,215 | $103.96 | $5M | −7,565 | −$2M | |
| ACHC — | Reduce −6.0% | 120,860 | $30.32 | $4M | −7,780 | −$1M | |
| GDX - Vaneck ETF Trust | Reduce −31.4% | 76,460 | $45.97 | $4M | −34,930 | −$262K | |
| OIH - Vaneck ETF Trust | Add +120.3% | 12,360 | $262.12 | $3M | +6,750 | +$2M | |
| GPRO - Gopro · CL A | Hold | 2,823,100 | $0.6629 | $2M | — | — | |
| GANX - Gain Therapeutics | Hold | 566,130 | $1.91 | $1M | — | — | |
| NUVB - Nuvation Bio · CL A | Hold | 34,995 | $1.76 | $62K | — | — |
Exits / last held
Not current holdings · last reported size, unchanged · gone vs 2024 Q4
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| CEIXEUR - Consol Energy | Exit | 0 | $106.68 | $149M | −1,394,641 | −$149M | |
| RSP — | Exit | 0 | $175.23 | $5M | −27,530 | −$5M | |
| Spdr Ser Tr | Exit | 0 | $79.59 | $5M | −59,810 | −$5M | |
| FCG - First Tr Exchange-Traded Fd | Exit | 0 | $24.64 | $2M | −70,830 | −$2M | |
| IVZ - Invesco Actvely Mngd Etc Fd | Exit | 0 | $12.99 | $2M | −117,360 | −$2M |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holds | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 46 | $3.9B | +22.5% | 13F-HR | 8/14/2026 | 000117266126003786 |
| 2026 Q1 | 45 | $3.2B | +12.0% | 13F-HR | 5/15/2026 | 000117266126002341 |
| 2025 Q4 | 41 | $2.8B | +12.1% | 13F-HR | 2/17/2026 | 000117266126001122 |
| 2025 Q3 | 37 | $2.5B | +9.3% | 13F-HR | 11/14/2025 | 000117266125005032 |
| 2025 Q2 | 34 | $2.3B | +17.8% | 13F-HR | 8/14/2025 | 000117266125003351 |
| 2025 Q1 | 33 | $2B | +1.5% | 13F-HR | 5/15/2025 | 000117266125002307 |
| 2024 Q4 | 36 | $1.9B | −19.1% | 13F-HR | 2/14/2025 | 000117266125001165 |
| 2024 Q3 | 38 | $2.4B | +17.6% | 13F-HR | 11/14/2024 | 000117266124005240 |
| 2024 Q2 | 39 | $2B | −6.5% | 13F-HR | 8/14/2024 | 000117266124003549 |
| 2024 Q1 | 42 | $2.2B | — | 13F-HR | 5/15/2024 | 000117266124002489 |
| 2023 Q4 | 40 | $2B | +16.3% | 13F-HR | 2/14/2024 | 000117266124001512 |
| 2023 Q3 | 39 | $1.8B | −17.4% | 13F-HR | 11/14/2023 | 000117266123004012 |
| 2023 Q2 | 41 | $2.1B | +15.9% | 13F-HR | 8/14/2023 | 000117266123003174 |
| 2023 Q1 | 39 | $1.8B | +27.4% | 13F-HR | 5/15/2023 | 000117266123002282 |
| 2022 Q4 | 42 | $1.4B | +2.3% | 13F-HR | 2/14/2023 | 000117266123001336 |
| 2022 Q3 | 42 | $1.4B | +9.8% | 13F-HR | 11/14/2022 | 000117266122002565 |
| 2022 Q2 | 47 | $1.3B | −18.3% | 13F-HR | 8/15/2022 | 000117266122002019 |
| 2022 Q1 | 52 | $1.6B | −10.0% | 13F-HR | 5/16/2022 | 000117266122001474 |
| 2021 Q4 | 57 | $1.7B | +17.2% | 13F-HR | 2/14/2022 | 000117266122000884 |
| 2021 Q3 | 58 | $1.5B | — | 13F-HR | 11/15/2021 | 000117266121002370 |
About
DME Capital Management
20 processed 13Fs on this site · 2021 Q3–2026 Q2